FdaApplication
NDA 215309
Identifiers
- fda_app_no: NDA215309
Properties
| Property | Value |
|---|---|
| applicant_name | INCYTE CORP |
| application_type | NDA |
| approval_date | 2021-09-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OPZELURA | RUXOLITINIB PHOSPHATE | EQ 1.5% BASE | CREAM;TOPICAL |
1 product